Pathway analysis involving expression and gene reporter for nuclear factor kappa B (NF-kB) indicated PAH EVs-derived miRs impacted NF-kB signaling through miR-486-5p and miR-26a-5p (Figure 5). The gene discussed is NFKB1; the disease is pulmonary arterial hypertension.